Avastin ® First Line and Where Applicable Beyond First Progression With Metastatic Colorectal Carcinoma
Avastin ® First Line and Where Applicable Beyond First Progression With Metastatic Colorectal Carcinoma
This observational multicenter study will evaluate the differences in progression-free survival defined in specific subgroups of participants with metastatic colorectal cancer receiving bevacizumab (Avastin). Further, safety and efficacy in daily routine will be assessed.
Inclusion Criteria:
Exclusion Criteria: